Grace Therapeutics, Inc. Cash and Restricted Cash
Grace Therapeutics, Inc. (GRCE) had Cash and Restricted Cash of $13.76 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.76M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.98M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.67M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.86M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $13.76M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $16.98M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $18.67M 10-Q · filed 2026-02-12 |
| 2025-09-30 | $16.86M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $20.00M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $22.13M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $11.05M 10-Q · filed 2026-02-12 |
| 2024-09-30 | $15.15M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $19.39M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $23.00M 10-K · filed 2026-06-18 |
| 2023-12-31 | $18.55M 10-Q · filed 2025-02-13 |
| 2023-09-30 | $26.99M 10-Q · filed 2024-11-13 |
| 2023-03-31 | $27.88M 10-K · filed 2025-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |